SCHEMBL4726101

SCHEMBL4726101

COC(CCCn1ccnn1)c1ccc(OCc2ccc(-c3ccc(C(F)(F)F)nc3)nc2C)cc1C

nearest known ligand 0.32

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TRPV3 Q8NET8 3/20 0.32
GRM2 Q14416 1/20 0.31
PSEN1 P49768 1/20 0.30
PSEN2 P49810 1/20 0.30
APH1B Q8WW43 1/20 0.30
NCSTN Q92542 1/20 0.30
APH1A Q96BI3 1/20 0.30
PSENEN Q9NZ42 1/20 0.30
ATP4A P20648 1/20 0.30
ATP4B P51164 1/20 0.30
ERBB2 P04626 1/20 0.30
MINK1 Q8N4C8 1/20 0.30
MAOA P21397 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4728989 0.91 TRPV3 (0.34) TRPV3GRM2PSEN1PSEN2APH1B
SCHEMBL4730718 0.90 GRM2 (0.34) TRPV3GRM2PSEN1PSEN2APH1B
SCHEMBL4784067 0.89 PPARD (0.32) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4728357 0.86 ERBB2 (0.37) TRPV3GRM2ATP4AATP4BERBB2
SCHEMBL4732040 0.83 TRPV3 (0.35) TRPV3GRM2PSEN1PSEN2APH1B
SCHEMBL4782623 0.82 PPARD (0.34) TRPV3GRM2ATP4AATP4BMAOA
SCHEMBL4780494 0.81 ERBB2 (0.46) TRPV3GRM2ATP4AATP4BERBB2
SCHEMBL4782456 0.80 PPARD (0.36) TRPV3GRM2ERBB2MINK1
SCHEMBL4784127 0.80 PPARD (0.33) TRPV3GRM2MAOA
SCHEMBL4730017 0.80 PSEN1 (0.34) GRM2PSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008034579-A1 2-HETEROCYCLYL-5-PHENOXYMETHYLPYRIDINE DERIVATIVES AS ANTICANCER AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2008-03-27 WO claimed
WO-2008034579-A1 2-HETEROCYCLYL-5-PHENOXYMETHYLPYRIDINE DERIVATIVES AS ANTICANCER AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2008-03-27 WO disclosed